MD HB1112

Expands duties of the Maryland Health Insurance Coverage Protection Commission to study and recommend measures for individual and group health insurance market stability

Requires the Commission to consider whether to adopt a direct payment system or fee-for-service model for Maryland Medical Assistance Program services

Directs exploration of regulatory exemptions allowing managed care organizations to sell in the individual market without full insurer capital requirements, and merging individual and small group markets to stabilize risk

Tasks the Commission with studying prescription drug cost controls (including a state pharmacy benefit administrator), sustaining federally qualified health centers through safety-net grants, and establishing a multiyear reinsurance stability fund

Requires consideration of reinstating the Maryland Health Insurance Plan, pooling purchasing power across states via interstate compact, and increasing premium assistance in the individual market

Takes effect July 1, 2026, and remains effective until the termination provision in Chapter 696 of the Acts of 2025 takes effect